Combined Estrogen-Progesterone Vaginal Preparations
There is no single branded "estrogen and progesterone cream" widely available as a combined vaginal formulation in standard clinical practice.
Available Vaginal Hormone Formulations
Estrogen-Only Vaginal Products
- Conjugated estrogens vaginal cream (Premarin Vaginal Cream) is FDA-approved for treatment of moderate to severe dyspareunia due to vulvar and vaginal atrophy associated with menopause 1
- 17β-estradiol vaginal gel can be administered at doses ranging from 0.5 to 1 mg daily 2
Combined Estrogen-Progesterone Formulations
For vaginal administration, the evidence describes:
- Vaginal suppositories containing estriol (1 mg) and progesterone (30 mg) have been studied for atrophic vaginitis, showing improved Vaginal Maturation Index, vaginal pH, and vaginal dryness without endometrial hyperplasia 3
- Vaginal micronized progesterone (200 mg) can be added cyclically for 12-14 days every 28 days when combined with transdermal or vaginal estradiol 2
Clinical Context for Combined Hormone Therapy
The preferred approach for combined estrogen-progesterone therapy uses separate administration routes:
- First choice: Transdermal 17β-estradiol patches (50-100 μg daily) combined with oral or vaginal micronized progesterone (200 mg for 12-14 days every 28 days) 2
- Alternative: Combined transdermal patches containing 17β-estradiol and levonorgestrel are available in some countries 2
Micronized progesterone (MP) is the preferred progestin due to lower cardiovascular and thromboembolic risk compared to synthetic progestins 2
Important Clinical Caveat
Combined estrogen-progesterone vaginal creams are not standard formulations in most markets. When endometrial protection is needed (in women with intact uterus), clinicians typically prescribe separate estrogen vaginal preparations with systemic or vaginal progesterone supplementation rather than a pre-mixed vaginal cream 2.